MIR A. IMRAN - 23 Oct 2025 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role
Director, 10%+ Owner
Signature
/s/ Svai Sanford, Attorney-in-Fact for Mir A Imran
Issuer symbol
RANI
Transactions as of
23 Oct 2025
Transactions value $
$1,260,417
Form type
4
Filing time
27 Oct 2025, 19:24:25 UTC
Previous filing
30 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
IMRAN MIR A Director, 10%+ Owner C/O RANI THERAPEUTICS LLC, 2051 RINGWOOD AVE., SAN JOSE /s/ Svai Sanford, Attorney-in-Fact for Mir A Imran 27 Oct 2025 0001031686

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RANI Class A Common Stock Purchase $1.26M +2.08M $0.61 2.08M 23 Oct 2025 Direct F1
holding RANI Class A Common Stock 74.1K 23 Oct 2025 See footnote F2
holding RANI Class B Common Stock 22.7M 23 Oct 2025 See Footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RANI Warrant to Purchase Class A Common Stock Purchase $0 +2.08M $0.00 2.08M 23 Oct 2025 Class A Common Stock 2.08M $0.48 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person purchased these shares in a PIPE offering conducted by the Issuer.
F2 The Reporting Person is a General Partner of InCube Ventures II, L.P. and Rani Investment Corp. InCube Labs, L.L.C. is wholly-owned by the Reporting Person and his family. Represents 52,781 shares of Class A Common Stock of the Issuer held by InCube Ventures II, L.P., 13,664 shares of Class A Common Stock of the Issuer held by InCube Labs, L.L.C., and 7,694 Class A Shares held by Rani Investment Corp. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
F3 The Reporting Person is a General Partner of InCube Ventures II, L.P., and InCube Labs, LLC is wholly-owned by the Reporting Person and his family. Represents 22,411,124 Class B Shares held by InCube Labs, LLC and 248,929 Class B Shares held by InCube Ventures II, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
F4 The warrants shall be exercisable upon stockholder approval and have a term of exercise equal to five years from the date of such stockholder approval.